Melillo R M, Helin K, Lowy D R, Schiller J T
Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland 20892.
Mol Cell Biol. 1994 Dec;14(12):8241-9. doi: 10.1128/mcb.14.12.8241-8249.1994.
E2F-1 is a member of a family of transcription factors implicated in the activation of genes required for the progression through the S phase of the cell cycle. We have examined the biological activities of E2F-1 with short-term colony-forming assays and long-term immortalization assays. High levels of E2F-1, produced by transfection of the E2F-1 cDNA under the control of a strong promoter, reduced colony formation in normal human foreskin keratinocytes (NHFKs). This inhibition could not be overcome by wild-type human papillomavirus type 16 (HPV16) E6 and E7, two proteins which cooperate to immortalize NHFKs, or by a transdominant p53 mutant. High levels of E2F-1 also inhibited growth of primary and established fibroblasts. The growth-inhibitory activity required the DNA binding function of E2F-1 but not its transactivation or pRB binding activities. A positive role for lower levels of E2F-1 in NHFK immortalization was established by examining the ability of E2F-1 to complement HPV16 E7 mutants that were unable to cooperate with HPV16 E6 to immortalize NHFKs. Although E2F-1 was unable by itself to cooperate with E6, it did, in conjunction with E6, complement a p24GLY mutant of E7 that is defective for immortalization and binding of pRB and pRB-related proteins. By contrast, E2F-1 was unable to complement two other E7 mutants, p2PRO and p31/32ARG/PRO, which are also defective in the immortalization assay, although their proteins display wild-type binding of pRB in vitro. Since the binding of E7 to pRB results in disruption of pRB-E2F interaction and release of transcriptionally active E2F, the data support the hypothesis that binding of pRB by E7 and the consequence increase in E2F, the data support the hypothesis that binding of pRB by E7 and the consequence increase in E3F activity are important but not sufficient for E7-induced keratinocyte immortalization.
E2F-1是转录因子家族的成员之一,该家族与激活细胞周期S期进程所需的基因有关。我们通过短期集落形成试验和长期永生化试验研究了E2F-1的生物学活性。在强启动子控制下转染E2F-1 cDNA产生的高水平E2F-1,降低了正常人包皮角质形成细胞(NHFKs)的集落形成。野生型人乳头瘤病毒16型(HPV16)的E6和E7这两种协同作用使NHFKs永生化的蛋白,以及一种显性负性p53突变体,均无法克服这种抑制作用。高水平的E2F-1也抑制原代和成纤维细胞的生长。生长抑制活性需要E2F-1的DNA结合功能,而不需要其反式激活或pRB结合活性。通过检测E2F-1补充HPV16 E7突变体的能力,确立了较低水平的E2F-1在NHFK永生化中的积极作用,这些HPV16 E7突变体无法与HPV16 E6协同作用使NHFKs永生化。虽然E2F-1自身无法与E6协同作用,但它与E6一起确实补充了E7的p24GLY突变体,该突变体在永生化以及与pRB和pRB相关蛋白的结合方面存在缺陷。相比之下,E2F-1无法补充另外两种E7突变体p2PRO和p31/32ARG/PRO,它们在永生化试验中也存在缺陷,尽管它们的蛋白在体外显示出野生型的pRB结合能力。由于E7与pRB的结合导致pRB-E2F相互作用的破坏以及转录活性E2F的释放,这些数据支持了这样的假说,即E7与pRB的结合以及随之而来的E3F活性增加对于E7诱导的角质形成细胞永生化很重要,但并不充分。